FDANonrulemakingFDA-2013-D-1275

Guidance for Industry on General Clinical Pharmacology Consideration for Pediatric Studies for Drugs and Biological Products

RIN

—

Last modified

Jan 8, 2026

Comment window

closed 1329d ago

American Academy of Pediatrics (AAP) filings

Activity

American Academy of Pediatrics (AAP) filed 1 comment on this docket between Feb 25, 2015 and Feb 25, 2015. 2 other organizations filed here. The comment window closed 1329d ago.

What American Academy of Pediatrics (AAP) filed (1)

Feb 25, 2015· Comment from American Academy of Pediatrics· FDA-2013-D-1275-0012

Attached please find comments from the President of the American Academy of Pediatrics on the General Clinical Pharmacology Considerations for Pediatric Studies for Drugs and Biological Products Draft Guidance for Industry.

View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (2)

See everyone who commented →

American Academy of Pediatrics (AAP)THIS ORG
1 filing · confidence 97%
Association of Clinical Research Professionalstrade assoc.
1 filing · confidence 85%
International Society of Pharmacometricstrade assoc.
1 filing · confidence 85%